DAI provides potential imaging biomarker to indicate brain tumor response to RT

Diffusion abnormality index shows promise as an imaging biomarker to measure brain tumor response to radiation therapy, according to research being presented at the 2013 Cancer Imaging and Radiation Therapy Symposium. This Symposium is sponsored by the American Society for Radiation Oncology and the Radiological Society of North America. Read more here.